5HMI | Ligase Ligase Inhibitor | date | Jan 16, 2016 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Hdm2 In Complex With A 3,3-Disubstituted Piperidine | ||||||||||||||
authors | G.Scapin | ||||||||||||||
compound | source | ||||||||||||||
Molecule: E3 Ubiquitin-Protein Ligase Mdm2 Chain: A, B Synonym: Double Minute 2 Protein,Hdm2,Oncoprotein Mdm2,P53- Protein Mdm2; Ec: 6.3.2.- Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Mdm2 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.74 Å | ||||||||||||
ligand | 62T, SO4 | enzyme | Ligase E.C.6.3.2 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors., Bogen SL, Pan W, Gibeau CR, Lahue BR, Ma Y, Nair LG, Seigel E, Shipps GW Jr, Tian Y, Wang Y, Lin Y, Liu M, Liu S, Mirza A, Wang X, Lipari P, Seidel-Dugan C, Hicklin DJ, Bishop WR, Rindgen D, Nomeir A, Prosise W, Reichert P, Scapin G, Strickland C, Doll RJ, ACS Med Chem Lett. 2016 Jan 20;7(3):324-9. doi: 10.1021/acsmedchemlett.5b00472., eCollection 2016 Mar 10. PMID:26985323 |
Data retrieval |
View 5HMI in 3D |
Visual 3D analysis of 5HMI |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5HMI |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |